Phase 1b trial results published
The Phase 1b clinical trial is detailed in a new article in European Urology Open Science.
The Phase 1b clinical trial is detailed in a new article in European Urology Open Science.
Dean Khaledi presented Sherri the award for Outstanding Achievement in Research from UTA’s College of Science!
The votes are in at the American Society for Photobiology: Sherri McFarland is the new President Elect! https://photobiology.org/
Sherri was interviewed in Fort Worth Report about photodynamic therapy and our lab’s research. With audio.
Our high potency hypoxia-active cancer agents are featured in this news release from UTA.
Sam Baker of North Texas NPR station KERA interviewed Sherri about our group’s work.
We had good representation at this conference. Elam gave a talk Synthesis and Characterization of Os(II) Oligothienyl Complexes for Photodynamic Therapy Applications, Houston gave a poster Rational Design and Development of a New Class of Metal-Based Photosensitizers for Photodynamic Therapy, and Ge presented a poster Metal-based photosensitizers: approaches to enhance…
Three group members presented their research at the ACS Fall 2021 meeting. Undergraduate Wesley McDonald presented a poster Toward Hypoxia Active Ru(II) Complexes for Cancer Phototherapy, grad student Houston Cole gave a talk Synthesis, Characterization, and Evaluation of a New Class of Metal Complex Photosensitizers, and post-doc Elam Ramasamy gave…